Anzol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Anzol

Anzol is a synthetic pharmacological preparation primarily used to manage conditions related to excessive stomach acid production. Its identity is defined by its active ingredient, Ranitidine Hydrochloride (INN: Ranitidine), which belongs to the class of medicines known as Histamine H₂-receptor antagonists, or H₂-blockers.


Quick Facts about Anzol

Property Description
Active Ingredient Ranitidine Hydrochloride
Pharmacological Class Histamine H₂-receptor antagonist (H₂-blocker)
Key Forms Tablet, Capsule, Solution for Injection
Origin Synthetic (chemically derived)
General Purpose Gastric acid output reduction

What Type of Medicine is Anzol and Its Classification?

Anzol is classified as a Histamine H₂-receptor antagonist, which is a widely clinically recognized type of medicine for controlling stomach acidity. This synthetic, single-ingredient product uses the Ranitidine Hydrochloride molecule to achieve its therapeutic effect. The H₂-blocker classification places Anzol in a group of acid-reducing drugs that operate differently from Proton Pump Inhibitors (PPIs). This medicine functions through selective competitive inhibition, which supports its role in managing acid-related issues. The Ranitidine formulation is frequently positioned for rapid onset of action compared to some other long-acting acid reducers.

Composition, Origin, and Available Forms

The therapeutic action of Anzol is entirely attributable to Ranitidine Hydrochloride, making it a single-ingredient product. The drug is manufactured in multiple pharmaceutical preparations to suit different patient needs. These forms include the Tablet and Capsule for Oral administration, as well as a Solution for Injection (Ampoule) intended for Intravenous (Parenteral) delivery. These various forms ensure the drug can be systemically absorbed to achieve its intended therapeutic purpose.

What is the General Therapeutic Purpose of Anzol?

The general purpose of Anzol is the robust and sustained Gastric acid output reduction within the stomach and the upper digestive tract. By acting as a Histamine H₂-receptor antagonist, the drug's role is to minimize the corrosive effects of gastric contents. As a functional Antiulcer agent, the drug's primary benefit is creating a reduced-acidity environment that facilitates the natural healing of irritated mucous membranes, a typical use being the relief of heartburn or acid indigestion.

Regulatory References

  1. H2 Blockers - StatPearls - NCBI Bookshelf
  2. FDA Ranitidine Tablets Drug Label (via DailyMed/NIH)

What side effects are possible with Anzol?

Official Safety Profile and Adverse Reactions

The safety profile of Anzol (Ranitidine Hydrochloride) is formally categorized in regulatory documents, defining reactions by frequency and the body system affected. These classifications distinguish between generally uncommon effects and those that are rare but clinically significant.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on their reporting rate in clinical use:

  • Uncommon reactions include gastrointestinal effects such as abdominal pain, constipation, and nausea. These symptoms may often improve with continued use.
  • Rare reactions documented in official labeling include hypersensitivity reactions (e.g., urticaria, bronchospasm), skin rash, and changes in liver function tests.
  • Very Rare reactions include serious events such as blood disorders (agranulocytosis, aplastic anemia), cardiac arrhythmias, and acute pancreatitis.

System-Organ Classes and Serious Events

Side effects are mapped to physiological systems, including Gastrointestinal Disorders, Nervous System Disorders (e.g., headache, reversible mental confusion), and Hepatobiliary Disorders.

Serious adverse reactions specifically highlighted in regulatory safety documents include:

  • Hepatitis (hepatocellular, cholestatic, or mixed) and rare cases of hepatic failure, which require immediate discontinuation.
  • Severe hypersensitivity reactions, including anaphylactic shock, which have been reported even after a single dose.
  • Serious blood and lymphatic system disorders, such as pancytopenia and agranulocytosis.

Safety Considerations and Restrictions

Safety documents contain constraints for specific patient groups. Dosage adjustment is required for patients with severe renal impairment as the drug is primarily kidney-excreted. Reversible mental confusion and hallucinations are reported predominantly in elderly and severely ill patients. Furthermore, official labeling notes that symptomatic relief does not preclude the presence of a gastric malignancy (cancer), and this possibility must be excluded before initiating therapy. There is also an officially noted increased risk of community-acquired pneumonia in current users of this drug class.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents indicate that clinical experience regarding Anzol (Anastrozole) overdose is limited. Acute single doses causing life-threatening symptoms have not been established; high doses administered during clinical trials (up to 60 mg) were generally well tolerated, showing low acute toxicity. No specific toxicological syndrome unique to Anzol overdose is documented. Potential nonspecific effects may include feeling sick, vomiting, or diarrhea.


Management and Emergency Action

Feature Official Regulatory Statement
Antidote Availability No specific antidote is known.
Management Protocol Treatment must be symptomatic, consisting of general supportive care and frequent monitoring of vital signs. The possibility of ingestion of multiple agents must be considered.
Urgent Medical Help You must seek emergency medical attention immediately or contact a poison control center if an overdose is suspected. Call emergency services if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

The regulatory guidance for Anzol overdose emphasizes immediate emergency contact and supportive treatment due to the absence of a specific antidote or a known unique toxic profile. Close medical observation is required to manage any resulting symptoms.

Therapeutic Uses of Anzol

Quick Facts

  • Helps manage hormone receptor-positive early breast cancer in postmenopausal women.
  • May be used for first-line treatment of locally advanced or metastatic hormone receptor-positive breast cancer.
  • An option for advanced breast cancer following progression after tamoxifen therapy.

Anzol (anastrozole) is a prescription medication utilized in the treatment regimen for certain types of breast cancer in postmenopausal women. The drug is indicated for the adjuvant treatment of early breast cancer that is classified as hormone receptor-positive.

For postmenopausal women with locally advanced or metastatic breast cancer that is hormone receptor-positive, Anzol may be used as a first-line treatment option. Furthermore, it is a therapeutic option for individuals with advanced breast cancer when the condition has progressed following prior tamoxifen therapy. This medication is part of a supervised care plan and is designed to address specific needs within the established guidelines for the condition.

Eligibility and Restrictions for Use

The official eligibility profile for Anzol is strictly defined by regulatory documents, primarily restricting its use to a specific patient population and excluding those with certain medical conditions or physiological states.

Populations Not Eligible (Contraindications)

Category Exclusion Criteria
Hypersensitivity Patients with known, demonstrated hypersensitivity to the drug substance or any of its inactive components.
Endocrine Status Women of premenopausal endocrine status, which explicitly includes pregnant women.
Reproductive Status Pregnancy and Lactation (Breastfeeding) are generally contraindicated due to the risk of fetal harm or uncertain risk to the infant.

Populations for Whom Use is Restricted

Official labeling defines eligibility based on a postmenopausal state for female patients. Use in pediatric populations (children and adolescents) is not established in the authorized indications. Special consideration, often requiring caution or monitoring, is necessary for patients with pre-existing conditions such as severe hepatic impairment or ischemic heart disease, though these are typically not absolute contraindications unless the impairment is marked or severe. The eligibility structure requires all individuals to be screened for these exclusions prior to initiating treatment.

What should I know about interactions with other medicines?

Anzol Interactions with other medicines and products

Official regulatory information describes two distinct interaction profiles for the active ingredients associated with 'Anzol': Ranitidine Hydrochloride ( H2-blocker) and Anastrozole (Aromatase Inhibitor).

Active Ingredient Interaction Type Specific Interacting Substances Regulatory Action/Constraint
Anastrozole Hormonal Antagonism/Exposure Reduction Tamoxifen, Estrogen-containing therapies Contraindicated (Must not be co-administered)
Ranitidine pH-Dependent Absorption Atazanavir, Ketoconazole, Dabigatran Etexilate, Itraconazole Reduced systemic exposure of the co-administered drug
Ranitidine Renal Transporter Inhibition Procainamide Increased plasma concentration of Procainamide

For Ranitidine, an administration interval of at least 2 hours is recommended by some authorities when co-administering with high doses of Sucralfate to maintain Ranitidine's absorption. Interactions may be more pronounced in patients with renal impairment due to reduced clearance of Ranitidine itself and interacting substances. For Anastrozole, no clinically significant interactions mediated by the cytochrome P450 system are documented in official prescribing information. No interactions with food or alcohol are officially specified for either active ingredient in major regulatory labels.

Mechanism of Action

Targeting the Histamine H₂ Receptor

The active component of Anzol, Ranitidine, works through selective competitive antagonism, acting on the Histamine H2 receptor ( H2-receptor) located on the gastric parietal cells. By binding to this receptor, Ranitidine directly blocks the action of the natural stimulant Histamine, initiating the modulation of the Histamine-driven secretory process.


Interruption of the Acid Secretion Cascade

Blocking the H2-receptor prevents the necessary activation signal from reaching the final acid-secreting pump. This action suppresses the signaling sequence involving the intracellular messenger cAMP, resulting in the indirect modulation of the H^+/ K^+-ATPase (Proton Pump) enzyme.


Resulting Decrease in Gastric Acid Output

The entire mechanistic cascade modifies early molecular steps that result in a physiological change: a decrease in Gastric Acid Output. This physiological change establishes an environment of reduced HCl concentration, which is the core system-level effect of the mechanism.

Dosage and Administration Information

Anzol is administered via three officially recognized routes: oral, intravenous (IV), and intramuscular (IM). The official administration protocol is defined by fixed dosing regimens, which vary based on the required use pattern. For active treatment, the standard oral dose is typically 150 mg twice daily or 300 mg once daily at bedtime. Long-term maintenance therapy generally follows a pattern of 150 mg once daily. Parenteral administration in acute settings follows a schedule of 50 mg every 6 to 8 hours.


The overall use of the drug is structured around defined time-bound cycles, such as short-term courses of 4 to 8 weeks for active treatment or long-term maintenance extending up to one year. The methodology requires specific preparatory steps depending on the form: Effervescent tablets must be fully dissolved in water before ingestion, and oral absorption is not significantly affected by taking the medicine with food. For injectable forms, the solution must be diluted prior to IV bolus or intermittent infusion, and the administration rate must be slow (e.g., bolus over at least 5 minutes).


A key constraint relates to patient physiology. A mandatory dose adjustment is specified for adults with severe renal impairment (creatinine clearance < 50 mL/min), where the dosing frequency for both oral and parenteral use is extended to every 18 to 24 hours. This frequency adjustment protocol defines standardized use under altered physiological conditions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Anzol (Ranitidine)


Evidence for Short-Term Treatment of Gastric and Duodenal Ulcers

Research has extensively examined the use of Anzol (ranitidine) in individuals with active ulcers in the stomach lining (gastric ulcers) or the upper part of the small intestine (duodenal ulcers). The available evidence includes many short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were used in research exploring how ulcers change over time and how physical discomfort may evolve during the treatment period. Studies focusing on acute ulcer healing reported patterns in the observed populations where endoscopic examinations showed the resolution of ulcer lesions within a defined timeframe. Research monitored changes measured during the study period, including patient-reported outcomes describing perceived discomfort.

Evidence for Use in Gastroesophageal Reflux Disease (GERD) and Heartburn

Research has examined the use of Anzol in patients with symptoms associated with Gastroesophageal Reflux Disease (GERD). Studies also explored outcomes related to the healing of erosive esophagitis (inflammation and lesions in the esophagus). These studies explored outcomes related to systemic or functional imbalance, such as the frequency and intensity of heartburn. Findings included patterns where a reduction in the self-reported frequency of heartburn was measured. Comparative evidence against other classes of acid suppressants for severe erosive esophagitis reported varied results regarding the healing of inflammatory states in the esophagus.

Long-Term Studies and Maintenance of Ulcer Healing

Research has also examined the use of Anzol in the maintenance of ulcer healing. These studies explored how to sustain an ulcer-free status after acute treatment, with follow-up durations extending for periods such as six months or one year. Findings describe patterns observed in these studies regarding the rate of ulcer relapse when treatment was continued versus when a placebo was used. Because the current approach to treating most ulcers emphasizes H. pylori testing and treatment, some of the older studies provide evidence that exists within the context of standards of care predating this change.

What is Still Uncertain and Research Gaps

While extensive research has explored Anzol, the evidence landscape still contains specific gaps. The long-term effects are not fully established for all potential complications, as many initial trials had follow-up durations that were limited. Data for certain groups remain insufficient, particularly for patients with specific comorbidities or for subgroup findings outside of the primary trial populations. Research does not determine whether an individual will respond similarly, and findings describe group patterns, not personal outcomes.

Key Studies & References

  1. ranitidine hydrochloride tablet - Official Labeling/Monograph for Ranitidine
  2. Ranitidine: Side Effects, Uses, Dosage, Interactions, Warnings (Professional drug reference covering ZES and pediatric context)

Frequently Asked Questions (FAQ)

Common questions about Anzol (FAQ)

Q: How quickly does Anzol usually start working?

Regulatory documents state that symptomatic relief is reported to begin approximately 60 minutes following a single oral dose. This initial effect is documented to last for a period of up to 10 hours.


Q: What is the typical timeframe before noticing an effect from Anzol?

Official information indicates that noticeable symptomatic relief is reported to occur within the first 24 hours of starting oral treatment. The duration of the therapeutic effect after a single dose is generally described as lasting for up to 10 hours.


Q: How long does Anzol stay in the body after stopping its use?

Official pharmacological information indicates the drug’s elimination half-life is typically 2.5 to 3.0 hours in individuals with normal kidney function. The half-life describes the time period needed for half of the drug to be cleared from the plasma, and this process can take longer in individuals with reduced kidney function.


Q: What is the difference between Anzol and other similar drugs mentioned in research?

This drug is officially classified as a Histamine H2-receptor antagonist (an H2-blocker), which functions differently from Proton Pump Inhibitors (PPIs). Research has also compared this drug class to Proton Pump Inhibitors (PPIs) in the context of healing certain severe conditions.


Q: Can Anzol be taken with common over-the-counter pain relievers?

Official patient information notes that this drug may interact with non-steroidal anti-inflammatory drugs (NSAIDs). It is also documented that the body's processing of certain pain relievers, such as acetaminophen, may be decreased. Patients are generally advised to discuss all co-administered medications with a healthcare provider.


Q: Is Anzol known to be addictive or habit-forming?

No. Regulatory agencies have classified this medication as having no known potential for abuse or habit formation. Furthermore, official listings indicate that the medication is not listed as a controlled substance.


Q: Are there non-active ingredients in Anzol that can cause reactions?

Yes, regulatory labels list all specific inactive ingredients in the different forms of the medication, which can include colorants, common tablet binders, and sweeteners like aspartame. Hypersensitivity (an allergic reaction) to any of these inactive components is a documented contraindication for the drug.


Q: Does Anzol impact fertility or sexual function?

Official studies report no effect on sperm count, motility, or morphology in men, and no known changes to estrogen or androgen levels. Very rare cases of impotence (sexual dysfunction) have been reported.


Q: What happens when Anzol is taken with high doses of Sucralfate?

Regulatory information notes that co-administration with high doses of Sucralfate may lead to reduced absorption of this medicine. Regulatory information advises that an interval of at least 2 hours between the two medicines be considered to prevent this reduction.


Q: Does Anzol affect your energy levels?

Official product documents list several effects that may relate to energy levels, including insomnia (difficulty sleeping) and somnolence (drowsiness). A general feeling of discomfort or unease, known as malaise, is also listed as a reported adverse effect.


Q: Is it normal to feel a mild headache when first starting Anzol?

Headache is listed in official documents as a reported adverse effect of the medication, sometimes severe. Official patient information does not specify whether headache is more common when first starting treatment or classify it as 'mild.'


Q: Is Anzol suitable for use in elderly patients?

Special caution is officially advised when this medicine is used by elderly patients. This is due to a documented risk of reversible mental confusion or other central nervous system effects, particularly in those who are also severely ill. The body may also clear the medicine more slowly.


Q: Can Anzol be used by children?

Studies in pediatric populations (children and adolescents) have shown that the drug's action is similar to that in adults when body weight is taken into consideration. Its use is established for certain acid-related conditions in this population.


Q: Can a person with liver problems use Anzol?

Caution is advised when the drug is used by individuals with hepatic dysfunction (liver problems). This is because the medication is primarily metabolized (processed) by the liver, and impairment can alter the drug's effects and clearance.


Q: Is Anzol available over the counter, or is it prescription only?

The medication is available in both prescription and over-the-counter (OTC) forms. The OTC form is typically sold at a lower dose and is used for the self-treatment of common conditions like heartburn and acid indigestion.


Q: Does Anzol affect blood pressure or heart rate?

Isolated reports have noted changes to heart rate (both increase and decrease) and rhythm disturbances, known as cardiac arrhythmias, as very rare potential adverse effects. The patient labeling does not typically list effects on blood pressure.


Q: Can Anzol cause changes in mood or behavior?

Official labeling documents report central nervous system adverse effects, which can include changes in mental state. Specifically, agitation, reversible mental confusion, hallucinations, and depression are documented, especially in elderly or severely ill patients.


Q: Is there a maximum length of time Anzol is usually recommended for?

The duration of use is defined based on the condition being addressed. This ranges from short courses (e.g., 4 to 8 weeks) for active treatment, up to one year for maintenance therapy to prevent recurrence, and is limited to 14 days for over-the-counter self-treatment.


Q: What is the expected long-term safety profile of Anzol?

Official documentation notes that while extensive research exists, the long-term effects are not fully established for all potential complications, as many initial trials had limited follow-up periods. Safety is continually reviewed by regulatory bodies.


Q: How common are serious side effects from Anzol?

Serious adverse reactions are officially classified as rare or very rare events in regulatory documents. These serious events include specific blood disorders and severe hepatic events like hepatitis.


Q: Are there different brand names for the medication Anzol?

Yes, the active ingredient in Anzol is widely available under multiple brand names around the world. These can include trade names such as Zantac and various generic versions marketed as acid-reducer labels.


Q: What is the general expectation for people who take Anzol?

The general therapeutic expectation is the robust and sustained reduction of gastric acid output in the stomach. This reduction is reported to help relieve associated symptoms such as heartburn, with symptomatic relief often beginning within 24 hours of starting oral treatment.


Q: Can Anzol affect the effectiveness of birth control pills?

Official studies report no changes in estrogen or other hormone levels, and the medication has no antiandrogenic action (effects on male hormones). This indicates that there is no direct hormonal mechanism for the drug to affect the effectiveness of hormonal birth control.


Q: Are there any specific warnings related to driving or operating machinery while taking Anzol?

Due to reported adverse effects that include dizziness, somnolence (drowsiness), and reversible mental confusion, official guidance advises patients to exercise caution before driving or operating machinery.


Q: Can Anzol be taken on an empty stomach?

Yes, official prescribing information states that this medication may be taken with or without food. Taking the medicine with food is not described as having a significant effect on its oral absorption into the body.


Q: What should be done if an unusual or severe reaction occurs after taking Anzol?

If signs of a severe or unusual reaction occur (such as difficulty breathing, swelling, or yellowing of the skin/eyes), official guidance instructs patients that the medication should be stopped immediately and medical attention sought.


Q: Is Anzol considered a short-term or long-term medication?

The medication is officially used for both purposes. It is prescribed for short-term treatment (typically 4 to 8 weeks) for active conditions and is also used for long-term maintenance (e.g., up to one year) to help prevent the recurrence of symptoms.


Q: What happens if a dose of Anzol is missed?

Official patient information outlines that if a dose is missed, the general protocol is that the dose may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped.


Q: Can Anzol cause stomach upset?

Gastrointestinal effects are listed as uncommon side effects in official documents. These effects, which may fall under the general term 'stomach upset,' include nausea, vomiting, constipation, diarrhea, or abdominal pain.

How should Anzol be stored and disposed of?

How to Store and Dispose of Anzol?

Anzol (Anastrozole) tablets must be stored according to specific regulatory requirements to maintain product integrity and safety.


Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature, between 20 C and 25 C.
Protection Protect from excessive heat and moisture.
Container Keep in the original container and keep the container tightly closed.
Child Safety Keep this medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Anzol must not be disposed of by pouring it down a drain or discarding it in household trash. To ensure proper environmental handling, consult a pharmacist or local waste disposal service for the correct method for discarding the unused medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Anzol found in:

A-Z Index: